StemCo Biomedical Inc.
This article was originally published in Start Up
Executive Summary
StemCo Biomedical believes it has technologies that will increase the efficiency and effectiveness of stem cell transplantation, addressing and expanding an existing market. The company hopes that, in the long term, an effective stem cell transplantation therapy will reach new patient populations, for example, sufferers of autoimmune diseases. For the near term, however, the company is keeping focused on getting onto the research market products that demonstrate its particular expertise; the identification and selection of viable stem cells.